Recent data has shown renewed interest in the inhibition of xanthine oxidase system for preventing progression of atherosclerosis.21 Allopurinol a xanthine oxidase inhibitor is being extensively studied for its role as add-on therapy in stable IHD.22 It acts by reducing vascular oxidative stress resulting in endothelial stabilization. This evidence concerns the gene XDH and myocardial ischemia.